These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 38663338

  • 21. Genetic diversity and evolutionary analysis of human respirovirus type 3 strains isolated in Kenya using complete hemagglutinin-neuraminidase (HN) gene.
    Elusah J, Bulimo WD, Opanda SM, Symekher SL, Wamunyokoli F.
    PLoS One; 2020; 15(3):e0229355. PubMed ID: 32155160
    [Abstract] [Full Text] [Related]

  • 22. Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983.
    van Wyke Coelingh KL, Winter CC, Murphy BR.
    Virology; 1988 Jan; 162(1):137-43. PubMed ID: 2827373
    [Abstract] [Full Text] [Related]

  • 23. Parainfluenza virus type 3 outbreak in a neonatal intensive care unit.
    Maeda H, Haneda K, Honda Y.
    Pediatr Int; 2017 Nov; 59(11):1219-1222. PubMed ID: 29359411
    [Abstract] [Full Text] [Related]

  • 24. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
    van Wyke Coelingh KL, Winter CC, Tierney EL, Hall SL, London WT, Kim HW, Chanock RM, Murphy BR.
    J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
    [Abstract] [Full Text] [Related]

  • 25. Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein gene in human parainfluenza virus type 1 isolates from patients with acute respiratory infection between 2002 and 2009 in Yamagata prefecture, Japan.
    Mizuta K, Saitoh M, Kobayashi M, Tsukagoshi H, Aoki Y, Ikeda T, Abiko C, Katsushima N, Itagaki T, Noda M, Kozawa K, Ahiko T, Kimura H.
    Virol J; 2011 Dec 13; 8():533. PubMed ID: 22152158
    [Abstract] [Full Text] [Related]

  • 26. Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.
    Wyatt LS, Shors ST, Murphy BR, Moss B.
    Vaccine; 1996 Oct 13; 14(15):1451-8. PubMed ID: 8994321
    [Abstract] [Full Text] [Related]

  • 27. Genetic analysis of human parainfluenza virus type 3 obtained in Croatia, 2011-2015.
    Košutić-Gulija T, Slovic A, Ljubin-Sternak S, Mlinarić-Galinović G, Forčić D.
    J Med Microbiol; 2017 Apr 13; 66(4):502-510. PubMed ID: 28463659
    [Abstract] [Full Text] [Related]

  • 28. Current status of vaccines for parainfluenza virus infections.
    Sato M, Wright PF.
    Pediatr Infect Dis J; 2008 Oct 13; 27(10 Suppl):S123-5. PubMed ID: 18820572
    [Abstract] [Full Text] [Related]

  • 29. Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.
    Spriggs MK, Murphy BR, Prince GA, Olmsted RA, Collins PL.
    J Virol; 1987 Nov 13; 61(11):3416-23. PubMed ID: 2822951
    [Abstract] [Full Text] [Related]

  • 30. Phylogenetic and molecular analyses of human parainfluenza type 3 virus in Buenos Aires, Argentina, between 2009 and 2013: The emergence of new genetic lineages.
    Goya S, Mistchenko AS, Viegas M.
    Infect Genet Evol; 2016 Apr 13; 39():85-91. PubMed ID: 26780643
    [Abstract] [Full Text] [Related]

  • 31. Molecular Epidemiology of Human Parainfluenza Virus Type 3 in Children With Acute Respiratory Tract Infection in Hangzhou.
    Guo YJ, Li L, Lai QR, Wang YS, Li W.
    Influenza Other Respir Viruses; 2024 Jul 13; 18(7):e13351. PubMed ID: 38965872
    [Abstract] [Full Text] [Related]

  • 32. Parainfluenza virus type 3 infections in a hematology unit.
    Hohenthal U, Nikoskelainen J, Vainionpää R, Peltonen R, Routamaa M, Itälä M, Kotilainen P.
    Bone Marrow Transplant; 2001 Feb 13; 27(3):295-300. PubMed ID: 11277177
    [Abstract] [Full Text] [Related]

  • 33. A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.
    Garg R, Brownlie R, Latimer L, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    Antiviral Res; 2018 Oct 13; 158():78-87. PubMed ID: 30071204
    [Abstract] [Full Text] [Related]

  • 34. Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs.
    Garg R, Latimer L, Gomis S, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    Antiviral Res; 2019 Feb 13; 162():54-60. PubMed ID: 30550799
    [Abstract] [Full Text] [Related]

  • 35. A novel parainfluenza virus type 3 (PIV3) identified from goat herds with respiratory diseases in eastern China.
    Li W, Mao L, Cheng S, Wang Q, Huang J, Deng J, Wang Z, Zhang W, Yang L, Hao F, Ding Y, Sun Y, Wei J, Jiang P, Jiang J.
    Vet Microbiol; 2014 Nov 07; 174(1-2):100-6. PubMed ID: 25236986
    [Abstract] [Full Text] [Related]

  • 36. Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation.
    Iketani S, Shean RC, Ferren M, Makhsous N, Aquino DB, des Georges A, Rima B, Mathieu C, Porotto M, Moscona A, Greninger AL.
    mBio; 2018 Jul 03; 9(4):. PubMed ID: 29970463
    [Abstract] [Full Text] [Related]

  • 37. Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany.
    Geis S, Prifert C, Weissbrich B, Lehners N, Egerer G, Eisenbach C, Buchholz U, Aichinger E, Dreger P, Neben K, Burkhardt U, Ho AD, Kräusslich HG, Heeg K, Schnitzler P.
    J Clin Microbiol; 2013 Jan 03; 51(1):155-62. PubMed ID: 23100345
    [Abstract] [Full Text] [Related]

  • 38. [An outbreak of parainfluenza 3 virus infection in the elderly in a ward].
    Yamakoshi M, Suzuki K, Yamamoto T, Shinagawa N, Nakakita T, Goto N, Yamada Y, Itoh M.
    Kansenshogaku Zasshi; 1999 Apr 03; 73(4):298-304. PubMed ID: 10356886
    [Abstract] [Full Text] [Related]

  • 39. Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis.
    Nichols WG, Erdman DD, Han A, Zukerman C, Corey L, Boeckh M.
    Biol Blood Marrow Transplant; 2004 Jan 03; 10(1):58-64. PubMed ID: 14752780
    [Abstract] [Full Text] [Related]

  • 40. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC, Wenzke DR, McAuliffe JM, St Claire M, Elkins WR, Murphy BR, Collins PL.
    J Virol; 2002 Feb 03; 76(3):1089-99. PubMed ID: 11773385
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.